Skip to main content
. 2021 Jan;60(1):77–84. doi: 10.30802/AALAS-JAALAS-20-000045

Table 2.

Comparisons of withdrawal thresholds recorded by using RM0.09 at different time points before (baseline) and after injection of carrageenan into the left hindpaw

RM0.9 P (95% CI) RM0.5 P (95% CI) RM 0.09 P (95% CI)
baseline
 1st compared with 1st–3rd average >0.99 (–11.0 to 11.1) 0.83 (–13.6 to 8.3) 0.25 (–1.7 to 8.9)
 1st compared with 1st–5th average 0.98 (–10.3 to 11.9) 0.65 (–15.0 to 6.9) 0.08 (–0.4 to 10.2)
 1st–3rd compared with 1st–5th average 0.99 (–10.4 to 11.8) 0.95 (–12.4 to 9.6) 0.84 (–4.0 to 6.7)
3 h
 1st compared with 1st–3rd average 0.96 (–9.8 to 12.4) 0.95 (–9.5 to 12.4) 0.98 (–4.9 to 5.8)
 1st compared with 1st–5th average 0.95 (–9.6 to 12.5) 0.87 (–8.6 to 13.3) 0.96 (–4.7 to 5.9)
 1st–3rd compared with 1st–5th average >0.99 (–11.0 to 11.2) 0.98 (–10.1 to 11.8) >0.99 (–5.1 to 5.5)
6 h
 1st compared with 1st–3rd average 0.93 (–9.4 to 12.7) 0.95 (–9.6 to 12.3) 0.94 (–4.6 to 6.0)
 1st compared with 1st–5th average 0.96 (–9.8 to 12.3) 0.86 (–8.5 to 13.4) 0.81 (–3.9 to 6.7)
 1st–3rd compared with 1st–5th average >0.99 (–11.5 to 10.7) 0.97 (–9.9 to 12.0) 0.95 (–4.6 to 6.0)
9 h
 1st compared with 1st–3rd average 0.94 (–9.5 to 12.7) >0.99 (–11.0 to 10.9) 0.99 (–5.0 to 5.6)
 1st compared with 1st–5th average 0.94 (–9.5 to 12.7) 0.96 (–9.7 to 12.2) 0.99 (–4.9 to 5.7)
 1st–3rd compared with 1st–5th average >0.99 (–11.0 to 11.1) 0.96 (–9.7 to 12.2) >0.99 (–5.3 to 5.4)
24 h
 1st compared with 1st–3rd average 0.99 (–10.6 to 11.6) >0.99 (–11.0 to 10.9) 0.99 (–5.1 to 5.5)
 1st compared with 1st–5th average 0.90 (–9.0 to 13.1) 0.99 (–10.8 to 11.1) 0.88
 1st–3rd compared with 1st–5th average 0.94 (–9.5 to 12.6) 0.99 (–10.7 to 11.2) 0.92